CCN2 and pemphigus foliaceus: Both prophylactic and therapeutic administration of Shenks significantly reduces BLM-induced PF in C57BL/6 female mice, decreasing lung collagen content and mRNA levels of Col1a1, Col1a2, Col3a1, connective tissue growth factor (CTGF), and TGF-β.